eflornithine has been researched along with Infarction, Middle Cerebral Artery in 1 studies
Eflornithine: An inhibitor of ORNITHINE DECARBOXYLASE, the rate limiting enzyme of the polyamine biosynthetic pathway.
eflornithine : A fluoroamino acid that is ornithine substituted by a difluoromethyl group at position 2.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Temiz, C | 1 |
| Dogan, A | 1 |
| Baskaya, MK | 1 |
| Dempsey, RJ | 1 |
1 other study available for eflornithine and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Effect of difluoromethylornithine on reperfusion injury after temporary middle cerebral artery occlusion.
Topics: Animals; Brain Edema; Cerebral Infarction; Cerebrovascular Circulation; Disease Models, Animal; Dose | 2005 |